Results and discussion
We compared the ability of mouse Dkk1 (mDkk1), mDkk2 and mDkk3 to inhibit Wnt signalling in Xenopus embryos, using animal caps as an assay system. We measured induction of the direct Wnt target siamois [7, 8] by reverse transcription (RT)-PCR analysis following Xwnt8 mRNA injection ( Figure 1a) . Unlike dkk1 RNA, neither dkk2 nor dkk3 RNA inhibited siamois induction by Xwnt8. We also tested the effect of Dkks on Xwnt5a, which in the presence of human Fz5 (hFz5), signals via the Wnt/β-catenin pathway [9] . None of the Dkks was able to inhibit Xwnt5a/hFz5 signalling in this assay (Figure 1b) . To compare various Fz receptors [1, 10, 11] for their interaction with Dkk1, we used the Xenopus axis duplication assay as read out. Xwnt8 mRNA injection induces embryonic axis duplication, which can be rescued by coinjected dkk1 mRNA [3] . We then tested which coinjected Fz receptor could restore axis duplication in dkk1/Xwnt8-injected embryos. We found that fz2, 5 and 8 RNAs strongly, and mouse fz4 (mfz4) RNA, weakly blocked the Wnt inhibitory activity of Dkk1 (Figure 1c) . We conclude that only Dkk1 but not Dkk2 or 3 is able to inhibit Xwnt8 signalling and that Dkk1 can be blocked by and, therefore, acts upstream or at the level of Fz2, 5 and 8.
In the mdkk2 injection experiments, we noted that despite its inability to block Xwnt8 signalling, injected embryos frequently showed a dorsalised phenotype and induction of siamois expression (see, for example, Figure 1a ), indicating that the cDNA had some biological activity. This was unlike Dkk3 which was well produced and secreted but did not yield any phenotype upon mRNA injection either alone or in combination with RNA for various Fz receptors (data not shown). To analyse dkk2, we isolated a fulllength Xenopus dkk2 (Xdkk2) cDNA. Xdkk2 showed 76% identity at the amino-acid level with mDkk2 [12] (accession no. AF300197 (EMBL)); data not shown). Xdkk2 expression started only during organogenesis, in head mesenchyme, lens and somites (Figure 2a ). While this late expression makes a role for dkk2 during early Xenopus embryogenesis unlikely, we used Xenopus as an in vivo expression system to assay the properties of dkk2. In all assays, mdkk2 and Xdkk2 yielded similar responses, but mdkk2 was effective at lower mRNA doses.
Microinjection of dkk2 mRNA in ventral blastomeres frequently induced axis duplication although the response in different egg batches varied (Figure 2b ,c; and see Supplementary material). Complete axis duplication is characteristic of overexpressed genes that activate the Wnt/β-catenin pathway [2] . To investigate this possibility, we analysed the expression of marker genes in animal cap assays following mRNA injections (Figure 2d ,e). Unlike dkk1, both Xenopus and mouse dkk2 mRNA induced the direct Wnt target gene siamois, in addition to the dorsal marker genes noggin and chordin. Expression of the ventro-posterior marker Xvent1 was reduced. Injected dkk1 RNA also induces goosecoid (gsc) and represses Xvent1 as shown previously [3] , probably by inhibiting a ventro-posteriorising Wnt active in animal caps, but it never induces siamois. The dkk2 mRNA-injected caps became neuralised, as indicated by induction of the neural markers N-CAM and XAG1 ( Figure 2e ) and this occurred in the absence of mesoderm formation (assayed by detecting expression of Xbra and actin; Figure 2d ,e).
An even higher frequency of axis duplication and Wnt target gene induction (siamois, Xnr3) was observed when dkk2 RNA was coinjected with RNA for the Wnt receptor Xfz8 [11] , with which it strongly synergises (see Supplementary material). Furthermore, dkk2 and Xfz8 coinduced the luciferase reporter construct Top-Flash, carrying T-cell factor (TCF)-binding sites, which are directly activated by the TCF/β-catenin complex [13] (Figure 2f ). This activation was inhibited by the β-catenin antagonist glycogen-synthase kinase-3 (GSK-3) [14] [15] [16] (Figure 2g ). We conclude that dkk2 can activate the Wnt/β-catenin signalling pathway in early Xenopus embryos. When fz RNAs other than Xfz8 were tested for their ability to synergise with dkk2 in animal cap assays, hfz5 and Drosophila fz2 (Dfz2) RNAs induced siamois expression strongly, and mouse fz4 induced siamois expression weakly (Figure 2h) . Thus, Dkk2 interacts with the same subset of Fz receptors as Dkk1, but in the opposite way. In Xenopus, Wnt signalling before the midblastula transition (MBT) leads to axis duplication and induction of siamois expression, whereas forced Wnt expression after MBT induces microcephaly and cyclopia [17] . In the preceding experiments, we assayed Wnt signalling before MBT. To test the effect of Dkk2 on post-MBT Wnt signalling, we injected dkk2 as plasmid DNA, which becomes transcribed only after MBT. Embryos injected with pCS2dkk2 were microcephalic and cyclopic, and the same phenotype was observed with injected Xwnt8 plasmid DNA (Figure 3a-c; see Supplementary material) . Furthermore, coinjected dkk2 and Xwnt8 synergised to enhance the microcephalic phenotype as more embryos had no eyes (Figure 3d ; see Supplementary material). Unlike dkk2 which induced microcephaly, dkk1 rescued microcephaly induced by Xwnt8 (Figure 3d To determine whether Dkk2 acts universally as an activator of Wnt/β-catenin signalling, we analysed its effects in the human HEK293T cell line. This cell line has previously been shown to be Wnt responsive using the TopFlash reporter assay [18] . As expected, dkk1 DNA inhibited Wnt1 signalling in these cells but, surprisingly, so did dkk2 (Figure 4a) . We conclude that dkk2 can act as activator or inhibitor of Wnt/β-catenin signalling, depending on the cellular context.
To test whether the effect of Dkk2 on Wnt signalling was direct or indirect, for example, by inducing expression of another Wnt signal, we carried out animal cap assays in the presence of cycloheximide to block protein synthesis at MBT, when zygotic transcription starts. Figure 4b shows that, even in the presence of cycloheximide, dkk2/Xfz8 mRNAs coinduced siamois, indicating that the effect of Dkk2 on Wnt signalling is direct. Further evidence for the direct interaction of dkk2 with Xfz8 is the observation that they can synergise in axis duplication even when produced in different blastomeres (Figure 4c ). This indicates that Dkk2 acts in a paracrine fashion. Finally, Dkk2 does not derepress Wnt/β-catenin signalling by interfering with Wnt/Ca 2+ signalling [2, 19, 20] because protein kinase C (PKC) translocation in response to Xwnt5a [21] was unaffected by dkk2 (data not shown).
An important conclusion from this work is that Dkk2 represents a novel secreted factor capable of activating the Wnt/β-catenin pathway. The only other secreted proteins known to synergise with Fz receptors are the Wnt glycoproteins themselves [2] . Dkk2 can act in an opposite fashion to Dkk1, suggesting that the proteins function as mutual antagonists. In the mouse, the dkk1 and dkk2 genes are coordinately expressed during organogenesis in a multitude of organs, and their expression frequently is found in adjacent or partially overlapping domains [12] . This suggests that, in these tissues, the interplay of dkk1 and dkk2 coordinately modulates the Wnt/β-catenin pathway.
Supplementary material
Supplementary material including additional methodological detail and two tables showing quantitative data of the injection phenotypes is available at http://current-biology.com/supmat/supmatin.htm. 
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